Skip to main content
×
Login
Submit a Manuscript
Home
Journal
Current Issue
Archive
For Authors
Column Series
Research & Insight
Special Reports
Subscribe
Contact
Online Exclusives
Biosimilars Excellence Forum
Blogs
Expert Insights
Latest News
Mantle Cell Lymphoma Excellence Forum
Pathways Beyond Oncology
Topics
Comparative Effectiveness Research
Cost-Effectiveness Research
COVID-19 Updates
Guideline Updates
Health Economics and Outcomes Research
Health Technology
Real-World Data
Reimbursement
Value-Based Care
Specialties
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
B-Cell Lymphoma
Biosimilars
Bladder Cancer
Breast Cancer
CAR-T Therapies
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Cancer
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Immuno-Oncology
Kidney Cancer
Liver Cancer
Lung Cancer
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Skin Cancer
Supportive Care
Conferences
Oncology Clinical Pathways Congress
ASCO Gastrointestinal Cancers Symposium
ASCO Genitourinary Cancers Symposium
ASH Annual Meeting and Exposition
Oncology CME
About
Podcast
Podcast
High Symptom Burden Among Patients With Advanced Upper GI Cancer Undergoing Chemotherapy
February 19, 2021
Xin Shelley Wang, MD, MPH, discusses results from a real-world study exploring PROs of symptom burden and functioning among patients with advanced esophageal, gastroesophageal…
Podcast
High Symptom Burden Among Patients With Advanced Upper GI Cancer Undergoing Chemotherapy
February 19, 2021
Xin Shelley Wang, MD, MPH, discusses results from a real-world study exploring PROs of symptom burden and functioning…
Podcast
NCCN Guideline Adherence Improves Survival Outcomes in Anal Cancer
February 04, 2021
Priyanka Kumar, MD, discusses a recent study which analyzed adherence to the NCCN treatment guidelines for anal…
Podcast
High Economic Burden of HCC Treated With Loco-Regional Therapies
January 27, 2021
Brian Seal, PhD, RPh, MBA discusses results from a study which examined the lines of loco-regional therapies received…
Podcast
Real-World Practice Patterns and Predictors of Survival in Older Patients With MCL
January 15, 2021
David Bond, MD, discusses real-world clinical outcomes and predictors of survival in older patients with MCL treated in…
Podcast
Real-World Treatment Patterns, HCRU in Patients With CML Achieving Later Lines of Therapy
January 14, 2021
Ehab Atallah, MD, discusses results from a study evaluating treatment patterns in patients with CML achieving later…
Podcast
First-Line Ibrutinib Effective for CLL/SLL Irrespective of Cytogenetic or Mutational Risk Features
December 10, 2020
Jan Burger, MD, PhD, discusses an analysis of the RESONATE-2 and iLLUMINATE studies, which explored outcomes of first-…
Engaging Experts
Real-World Outcomes of First-Line Ibrutinib vs Chemoimmunotherapy for CLL
December 06, 2020
Lori Leslie, MD, discusses results from a real-world study evaluating clinical outcomes in high-risk and non-high-risk…
Podcast
Treatment Options for Patients With Relapsed/Refractory FL
October 15, 2020
Elizabeth Brem, MD, discusses data from studies exploring the best treatment approaches for patients with relapsed/…
Engaging Experts
Economic Burden of CML Treatment in the US: Before and After the Availability of Generic Imatinib
October 03, 2020
Gary Lyman, MD, Fred Hutchinson Cancer Research Center, discusses a project exploring the cost of TKIs, particularly…
Podcast
Assessing Response to Follicular Lymphoma Treatment
September 24, 2020
Peter Martin, MD, discusses the prognostic value of PET/CT status after long-term follow-up for recipients of first-…
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
››
Last page
Last »
Stay in the know.
Journal of Clinical Pathways Newsletter
Back to Top